Cérébrovasculaire pathologie And NotNathalie Tzourio-Mazoyer

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
003546	Myzoon Ali [Royaume-Uni] ; Philip M. W. Bath [Royaume-Uni] ; John Curram [Royaume-Uni] ; Stephen M. Davis [Australie] ; Hans-Christoph Diener [Allemagne] ; Geoffrey A. Donnan [Australie] ; Marc Fisher [États-Unis] ; Barbara A. Gregson [Royaume-Uni] ; James Grotta [États-Unis] ; Werner Hacke [Allemagne] ; Michael G. Hennerici [Allemagne] ; Marc Hommel [France] ; Markku Kaste [Finlande] ; John R. Marler [États-Unis] ; Ralph L. Sacco [États-Unis] ; Philip Teal [Canada] ; Nils-Gunnar Wahlgren [Suède] ; Steven Warach [États-Unis] ; Christopher J. Weir [Royaume-Uni] ; Kennedy R. Lees [Royaume-Uni]	The virtual international stroke trials archive
003959	Jacques Joubert [Australie] ; Toby B. Cumming [Australie] ; Allan J. Mclean [Australie]	Diversity of risk factors for stroke : The putative roles and mechanisms of depression and air pollution
003D54	Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]	Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial
004401	Stephan A. Mayer [États-Unis] ; Nikolai C. Brun [Danemark] ; Joseph Broderick [États-Unis] ; Stephen Davis [Australie] ; Michael N. Diringer [France] ; Brett E. Skolnick [États-Unis] ; Thorsten Steiner [Allemagne]	Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
004446	Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France]	Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease
004850	Gustavo C. Roman [États-Unis] ; Perminder Sachdev [Australie] ; Donald R. Royall [États-Unis] ; Roger A. Bullock [Royaume-Uni] ; Jean-Marc Orgogozo [France] ; Secundino Lopez-Pousa [Espagne] ; Raul Arizaga [Argentine] ; Anders Wallin [Suède]	Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia
004942	Pierre Amarenco [France] ; Geoffrey A. Donnan [Australie]	Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?
004A11	Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France]	Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary
004B73	N. Chapman [Royaume-Uni] ; R. Huxley [Australie] ; C. Anderson [Nouvelle-Zélande] ; M. G. Bousser [France] ; J. Chalmers [Australie] ; S. Colman [Australie] ; S. Davis [Australie] ; G. Donnan [Australie] ; S. Macmahon [Australie] ; B. Neal [Australie] ; C. Warlow [Royaume-Uni] ; M. Woodward [Australie]	Effects of a perindopril-based blood pressure-lowering regimen on the risk of Recurrent Stroke according to Stroke subtype and medical history: The PROGRESS trial

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024